The medical device company PolyMedics Innovations (PMI) is expanding its portfolio to include a one-sided non-adhesive wound dressing. SUPRA NET®, marketed in the U.S. under the name Rylon by BioMed Scienes, is an ideal complement to PolyMedics Innovations’ synthetic skin substitutes. A wound treated with SUPRA SDRM® or SUPRATHEL® finds an external closure with the SUPRA NET® wound dressing, which additionally promotes rapid wound healing.
Valuable properties of SUPRA NET®
SUPRA NET® is an atraumatic wound contact dressing. The hypoallergenic silicone-based material adapts to the wound surface and adheres to the surrounding intact skin surface. It provides an optimal environment for rapid wound healing and adapts to a wide range of wounds and skin types. SUPRA NET® does not absorb the liquid itself but must be combined with a secondary absorbent dressing. It is easy to handle and offers valuable properties in the control and handling of the fluid secreted by the wound. For the patient, SUPRA NET® means maximum comfort: it does not stick to the wound bed and minimizes pain during dressing changes.
Comprehensive portfolio for the treatment of traumatic and chronic wounds
“With SUPRA NET®, our portfolio has not simply grown by another product,” says Christian Planck, Managing Director of PolyMedics Innovations. “SUPRA NET® as a wound contact layer also represents another component within existing and future treatment concepts.”
Just recently, PolyMedics Innovations has expanded its portfolio for treating dermal and epidermal wounds: At the end of 2023, PMI has taken over the distribution of NexoBrid® and RECELL® for selected European countries. NexoBrid® is a non-surgical solution for the removal of necrotic tissue from burns. RECELL® from AVITA Medical is an autologous cell suspension that is applied in spray form.
Sensible addition to existing concepts
SUPRA NET® can be combined as a wound dressing and outer layer with SUPRATHEL® and SUPRA SDRM® as well as with NovoSorb® BTM. Polymedics Innovations distributes SUPRA NET® in Germany, Switzerland, Austria and other EU countries. In the USA, SUPRA NET® is mainly marketed by the manufacturer itself, BioMed Sciences, under the name Rylon.
“Experience reports confirm that the various products in our portfolio already complement each other optimally for a wide range of indications,” says PMI CEO Christian Planck. “With SUPRA NET®, we can cover another requirement within wound care.”